Workboat Indexes

Recent Quotes
My Watchlist
Indicators
Local Stocks
Markets
Workboat Indexes
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cara Therapeutics (NQ: CARA )

0.3301 -0.0199 (-5.69%)
Streaming Delayed Price Updated: 11:53 AM EDT, Aug 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Cara Therapeutics

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Cannabis Stock Movers For August 1, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bullish Friday For Marijuana Stocks - GreenGro Technologies, Leafbuyer Techs Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For July 25, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From July 24, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bullish Sentiment Across The Cannabis Space - Check Full Movers For July 16, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From July 15, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For July 12, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For July 11, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
What's Going On With Cara Therapeutics Stock?
Cara Therapeutics shares are trading higher by 15% during Thursday's session. The company earlier announced it engaged Piper Sandler & Co. as a financial advisor to explore strategic alternatives. 
Via Benzinga
Bearish Sentiment Across The Cannabis Space - Check Full Movers For July 10, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bearish Sentiment Across The Cannabis Space - Check Full Movers For July 5, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For July 2, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For July 1, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bearish Friday For Marijuana Stocks - Global Compliance, 1933 Industries Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From June 27, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bullish Wednesday For Marijuana Stocks - Affinor Growers, Blueberries Medical Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bearish Sentiment Across The Cannabis Space - Check Full Movers For June 25, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bullish Monday For Marijuana Stocks - Khiron Life Sciences, CordovaCann Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For June 19, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For June 17, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Marijuana Stock Movers For June 14, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
S&P 500 Edges Higher; J.Jill Shares Plunge
Via Benzinga
Topics Stocks
Exposures US Equities
Why Signet Jewelers Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
These Cara Therapeutics Analysts Are No Longer Bullish: 'We See No Obvious Future Value Drivers'
Cara Therapeutics plans to explore strategic alternatives. There are no meaningful development programs in the pipeline, analysts note. 
Via Benzinga
Gold Down 1%; Broadcom Shares Jump After Upbeat Results
Via Benzinga
Williams-Sonoma Stock Split: Mark Your Calendars for June 27
Williams-Sonoma is preparing for a stock split through dividend with the cutoff date for WSM shareholders set for June 27. 
Via InvestorPlace
Dow Tumbles Over 100 Points; US Producer Prices Decline In May
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Cara Therapeutics (CARA) Stock Down 27% Today?
Cara Therapeutics stock is down on Thursday as investors learn of a failed clinical trial and the company considering strategic alternatives. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Diversified Communications
© 2023 Diversified Communications. All rights reserved.